1. Llorca-Cardenosa, Marta J, Aronson, Lauren I, Krastev, Dragomir B, Lord, Christopher J, Chong, Irene Y. . SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance. In Cancer research, 82, 3962-3973. doi:10.1158/0008-5472.CAN-21-4339. https://pubmed.ncbi.nlm.nih.gov/36273494/
2. Yang, Qi, Qin, Zailong, Zhang, Qinle, Yi, Sheng, Luo, Jingsi. 2022. Identification of a novel compound heterozygous SMG9 variants in a Chinese family with heart and brain malformation syndrome using whole exome sequencing. In BMC medical genomics, 15, 67. doi:10.1186/s12920-022-01217-9. https://pubmed.ncbi.nlm.nih.gov/35321723/
3. Jin, Xing, Yin, Jie, Zhu, Hongling, Wan, Zemin, Huang, Xianzhang. 2021. SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma. In Frontiers in pharmacology, 12, 701454. doi:10.3389/fphar.2021.701454. https://pubmed.ncbi.nlm.nih.gov/34456727/
4. Tan, Yanjie, Ma, Zhenfa, Jin, Yi, Wu, Jian, Ren, Zhuqing. 2019. MicroRNA 4651 regulates nonsense-mediated mRNA decay by targeting SMG9 mRNA. In Gene, 701, 65-71. doi:10.1016/j.gene.2019.03.031. https://pubmed.ncbi.nlm.nih.gov/30902786/